| Announce Date | 10/27/2025 | 
| EPS Normalized Actual | $0.29 (Miss by $-0.01) | 
| EPS GAAP Actual | $0.29 (Miss by $-0.01) | 
| Revenue Actual | $1.0364B | 
| Revenue Surprise | Beat by $1036.4M | 
| Announce Date | 10/01/2025 (Pre-Market) | 
| EPS Normalized Estimate | $0.36667 | 
| EPS GAAP Estimate | $0.36667 | 
| Revenue Estimate | $1.157666667B | 
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts | 
|---|---|---|---|---|---|
| Dec 2029 | 1.56 | 6.11 | 1.53079 | 1.59789 | 1 | 
| Dec 2028 | 1.49 | 6.4 | 1.46204 | 1.51451 | 0 | 
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss | 
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 140.2 | 139.87 | 1.0364B | -6.3% | -119.13M | 
| FQ2 2025 (Jun 2025) | 0.38 | 0.03 | 1.058B | -6.67% | -114.45M | 
| FQ1 2025 (Mar 2025) | 0.22 | -0.07 | 1.0221B | -7.32% | -110.1M | 
| FQ4 2024 (Dec 2024) | 0.1 | -0.1875 | 1.0564B | -5.56% | -11.88M | 
| FQ3 2024 (Sep 2024) | 0.33 | 0.33 | 1.1017B | -6.69% | 1101.7M | 
| FQ2 2024 (Jun 2024) | -4.39 | -4.39 | 1.1286B | -8.2% | 1128.6M | 
| FQ1 2024 (Mar 2024) | 0.23 | 0.23 | 1.0969B | -10.64% | 1096.9M | 
| FQ4 2023 (Dec 2023) | -2.18 | -2.18 | 1.1151B | -7.24% | 1115.1M | 
FQ4 Announce Date
10/01/2025 (Pre-Market)
Consensus EPS Estimates
0.36667
Consensus Revenue Estimates
1.157666667B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts | 
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0.22 | -- | 0.20998 | 0.23064 | 1 | 
| FQ3 2027 (Sep 2027) | 0.3 | -- | 0.28634 | 0.31451 | 1 | 
| FQ2 2027 (Jun 2027) | 0.28 | -- | 0.26725 | 0.29354 | 1 | 
| FQ1 2027 (Mar 2027) | 0.28 | -- | 0.26725 | 0.29354 | 1 | 
| FQ4 2026 (Dec 2026) | 0.25 | -- | 0.24174 | 0.25849 | 1 | 
| FQ3 2026 (Sep 2026) | 0.36 | -38844.44 | 0.3481 | 0.37223 | 1 | 
| FQ2 2026 (Jun 2026) | 0.32 | -18.75 | 0.30942 | 0.33087 | 1 | 
| FQ1 2026 (Mar 2026) | 0.265 | 16.98 | 0.25624 | 0.274 | 1 | 
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts | 
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0.98B | -- | 0.94B | 1.01B | 2 | 
| FQ3 2027 (Sep 2027) | 1.08B | -- | 1.05B | 1.12B | 2 | 
| FQ2 2027 (Jun 2027) | 1.01B | -- | 0.98B | 1.05B | 2 | 
| FQ1 2027 (Mar 2027) | 0.97B | -- | 0.94B | 1.01B | 2 | 
| FQ4 2026 (Dec 2026) | 1.05B | -- | 1.02B | 1.08B | 2 | 
| FQ3 2026 (Sep 2026) | 1.09B | 4.76 | 1.06B | 1.12B | 2 | 
| FQ2 2026 (Jun 2026) | 1.08B | 1.62 | 1.05B | 1.1B | 2 | 
| FQ1 2026 (Mar 2026) | 1.04B | 1.41 | 1.01B | 1.06B | 2 | 
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts | 
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 | 
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 | 
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 | 
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 | 
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts | 
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 | 
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 | 
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 | 
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 | 
EPS # of Beats
4
EPS # of Misses
4
EPS # of in-lines
0
Revenue # of Beats
4
Revenue # of Misses
4
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % | 
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.33 | 140.2 | 139.87 | 99.76% | 
| FQ2 2025 (Jun 2025) | 0.35 | 0.38 | 0.03 | 7.89% | 
| FQ1 2025 (Mar 2025) | 0.29 | 0.22 | -0.07 | -31.82% | 
| FQ4 2024 (Dec 2024) | 0.2875 | 0.1 | -0.1875 | -187.5% | 
| FQ3 2024 (Sep 2024) | 0.33 | 0.33 | 100% | |
| FQ2 2024 (Jun 2024) | -4.39 | -4.39 | 100% | |
| FQ1 2024 (Mar 2024) | 0.23 | 0.23 | 100% | |
| FQ4 2023 (Dec 2023) | -2.18 | -2.18 | 100% | 
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % | 
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $1.16B | $1.04B | $-119.13M | -11.49% | 
| FQ2 2025 (Jun 2025) | $1.17B | $1.06B | $-114.45M | -10.82% | 
| FQ1 2025 (Mar 2025) | $1.13B | $1.02B | $-110.1M | -10.77% | 
| FQ4 2024 (Dec 2024) | $1.07B | $1.06B | $-11.88M | -1.12% | 
| FQ3 2024 (Sep 2024) | $0B | $1.1B | $1101.7M | 100% | 
| FQ2 2024 (Jun 2024) | $0B | $1.13B | $1128.6M | 100% | 
| FQ1 2024 (Mar 2024) | $0B | $1.1B | $1096.9M | 100% | 
| FQ4 2023 (Dec 2023) | $0B | $1.12B | $1115.1M | 100% |